Skip to main content
ConductScienceScienceDex
NIH funding notice RFA-DA-20-015

Development of Clinical Outcome Assessments for Clinical Trials in Substance Use Disorders as FDA-qualified Drug Development Tools (U01 Clinical Trial Optional)

Closed on October 23, 2019.

Posted
June 25, 2019
Close date
October 23, 2019
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $568,625 in first-year total cost, median $568,625.

Most frequent study sections

  1. Special Emphasis Panel[ZDA1 GXM-A (05)]1

Most frequent institutions

  1. YALE UNIVERSITY1
Competing awards under RFA-DA-20-015 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2020Development of the Opioid Use Disorder Severity Scale1U01DA051639-01KILUK, BRIAN D.YALE UNIVERSITY, CT$568,625ZDA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

Start your CVHow the NIH biosketch works